| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/24/2006 | WO2006088837A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006088071A1 Process for producing compound with anti-hcv potency and intermediate for use therein |
| 08/24/2006 | WO2006087480A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 08/24/2006 | WO2006087315A1 Novel, long-acting betamimetics for treating respiratory diseases |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/24/2006 | WO2006056850A3 Chroman compounds |
| 08/24/2006 | WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 08/24/2006 | US20060189665 Oxamide derivatives useful as raf-kinase inhibitors |
| 08/24/2006 | US20060189661 3-pyrid-2-yl-5-phenyl-1,2,4-oxadiazoles in which either the pyridine and/or phenyl rings are substituted; useful for treating neurological and psychiatric disorders such as stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, migraines, Parkinson's and Alzheimer's disease |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | US20060189630 Mitotic kinesin inhibitors |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189607 e.g. 8-(2-{3-[3-(4-fluoro-phenyl)-5-methyl-[1,2,4]triazol-1-yl]-1,1-dimethyl-propylamino}-1-hydroxy-ethyl)-6-hydroxy-4h-benzo[1,4]oxazin-3; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity |
| 08/24/2006 | US20060189606 comprising administering compounds that affect viral internal ribosome entry site (IRES) activity, such as [4-(3-cyano-1-ethyl-6-methoxy-1H-indol-2-yl)-phenyl]-carbamic acid ethyl ester |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189591 Five-membered heterocyclic derivative |
| 08/24/2006 | US20060189577 Tyrosine kinase inhibitors |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | DE102005007654A1 Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen New long-acting beta-mimetics for the treatment of respiratory disorders |
| 08/24/2006 | CA2598897A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | CA2598458A1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598457A1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598456A1 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598355A1 Novel, long-acting betamimetics for treating respiratory diseases |
| 08/24/2006 | CA2597962A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/24/2006 | CA2597359A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692117A1 Oxazole derivatives of tetracyclines |
| 08/23/2006 | EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692111A2 Quinolines useful in treating cardiovascular disease |
| 08/23/2006 | EP1692110A1 Diacylhydrazine derivatives |
| 08/23/2006 | EP1692108A1 Novel herbicides |
| 08/23/2006 | EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma |
| 08/23/2006 | EP1691810A1 Substituted piperazines |
| 08/23/2006 | EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | CN1823063A Quinoline derivatives as phosphodiesterase inhibitors |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1823057A Biaryl piperazinyl-pyridine analogues |
| 08/23/2006 | CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
| 08/23/2006 | CN1823046A Phenyl quinolines and their use as estrogenic agents |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/23/2006 | CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use |
| 08/23/2006 | CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094900 N-Aryl-2-oxazolidinones and their derivatives |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2006067311A3 Cdc25 phosphatase inhibitors |
| 08/17/2006 | WO2006060730A3 Potassium salt of an hiv integrase inhibitor |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006031782A3 Salvinorin derivatives as opioid receptor ligands |
| 08/17/2006 | WO2006007532A3 2-substituted heteroaryl compounds |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183897 Biaryl substituted triazoles as sodium channel blockers |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183740 Novel salt form of a dopamine agonist |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060182751 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689742A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 08/16/2006 | EP1689739A1 Azole-based kinase inhibitors |
| 08/16/2006 | EP1689738A2 Heterocyclic anti-migraine agents |
| 08/16/2006 | EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |